← Back to Search

Behavioral Intervention

Lymfit Exercise Program for Lymphoma Survivors (Lymfit_RCT Trial)

N/A

Recruiting

Research Sponsored by McGill University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Lymfit_RCT Trial Summary

This trial will test whether an exercise program using mobile technology can improve fitness and quality of life for lymphoma survivors.

Who is the study for?

This trial is for lymphoma survivors aged 18-39, who've had chemotherapy with curative intent in the last 6 months. Participants need approval from their hematologist to do vigorous exercise, must own a smartphone compatible with Fitbit, be able to complete online questionnaires, and have home internet for video coaching sessions.Check my eligibility

What is being tested?

The study is testing if a mobile-health supported exercise program called Lymfit can boost fitness and life quality in lymphoma survivors. It's a randomized control trial where some will enter the program immediately while others will be on a waitlist.See study design

What are the potential side effects?

Since this intervention involves an exercise program, potential side effects may include typical workout-related issues such as muscle soreness or strain. However, participants are pre-screened for any health conditions that could make vigorous exercise unsafe.

Lymfit_RCT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change of the exercise guideline as determined by comparing the active minutes captured in the Fitbit

Secondary outcome measures

Change from baseline Fear of Cancer Recurrence assessed by the Cancer Worry Scale (CWS)

Change from baseline Work Ability assessed by the Work Ability Index (WAI)

Change from baseline multi-dimensional Quality of life (QoL) assessed by the Patient-Reported Outcomes Measurement Information System-29

Lymfit_RCT Trial Design

2Treatment groups

Experimental Treatment

Group I: Waitlist controlExperimental Treatment1 Intervention

Participants will receive the exact same Lymfit exercise intervention 3 months after they consent to participate in the study.

Group II: Lymfit exercise interventionExperimental Treatment1 Intervention

Participants randomized to the intervention group will be allocated a pre-registered Fitbit, a personalized exercise prescription designed by the kinesiologist, and 12 weeks of supervision by the kinesiologist.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Waitlist control

2007

Completed Phase 2

~2450

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER

446 Previous Clinical Trials

159,676 Total Patients Enrolled

2 Trials studying Lymphoma

66 Patients Enrolled for Lymphoma

Jewish General HospitalOTHER

137 Previous Clinical Trials

271,994 Total Patients Enrolled

1 Trials studying Lymphoma

26 Patients Enrolled for Lymphoma

McGill UniversityLead Sponsor

395 Previous Clinical Trials

999,327 Total Patients Enrolled

3 Trials studying Lymphoma

81 Patients Enrolled for Lymphoma

Media Library

Lymfit exercise intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05257785 — N/A

Lymphoma Clinical Trial 2023: Lymfit exercise intervention Highlights & Side Effects. Trial Name: NCT05257785 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical research include elderly participants?

"This specific trial is open to patients aged between 18 and 39. In contrast, there are 308 clinical trials targeting underage participants and 1593 for persons over the age of 65."

Answered by AI

How extensive is the sampling size of this investigation?

"That is correct. The particulars on clinicaltrials.gov demonstrate that the study, initiated January 15th 2022, has a current call for volunteers with 50 spots open at one site."

Answered by AI

Are there still vacancies available to participate in this research?

"Affirmative. Clinicaltrials.gov shows that enrollment is still open for this research trial, which was first posted on January 15th 2022 and last edited on February 24th of the same year. Currently, 50 patients are being sought out at a single medical site."

Answered by AI

Is there a possibility I could partake in this trial?

"This research effort is seeking 50 participants aged 18-39 who have lymphoma. The list of prerequisites for enrolment include: a recent diagnosis confirmed by their hematologist, zero health issues impeding vigorous physical activity, chemotherapy administered within the last 6 months with curative intent in mind, possession of a mobile device compatible with Fitbit and capable of completing questionnaires online (in either French or English), access to an Internet connection that supports virtual coaching sessions through Zoom videoconferencing."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors

Christine Maheu 2022. "Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05257785.